Liminatus Pharma Forms Strategic Consortium with Samda and INNOCS AI to Advance Next-Gen Pancreatic Cancer Diagnostics
Liminatus Pharma, Inc (NASDAQ:LIMN) FULLERTON, CA, UNITED STATES, July 2, 2025 /EINPresswire.com/ -- Liminatus Pharma today announced that it has entered into a Memorandum of Understanding (MOU) to form a research and development consortium with …